S
42.76
-0.04 (-0.09%)
| 前收盘价格 | 42.80 |
| 收盘价格 | 42.33 |
| 成交量 | 1,174,461 |
| 平均成交量 (3个月) | 2,122,566 |
| 市值 | 4,361,838,592 |
| 价格/销量 (P/S) | 13.14 |
| 股市价格/股市净资产 (P/B) | 19.02 |
| 52周波幅 | |
| 利润日期 | 14 Nov 2025 |
| 稀释每股收益 (EPS TTM) | -2.55 |
| 总债务/股东权益 (D/E MRQ) | 20.22% |
| 流动比率 (MRQ) | 10.25 |
| 营业现金流 (OCF TTM) | -229.84 M |
| 杠杆自由现金流 (LFCF TTM) | -134.32 M |
| 资产报酬率 (ROA TTM) | -50.15% |
| 股东权益报酬率 (ROE TTM) | -106.71% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Scholar Rock Holding Corporatio | 看涨 | 看涨 |
AIStockmoo 评分
-0.4
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -3.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.5 |
| 平均 | -0.38 |
|
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 4.35% |
| 机构持股比例 | 118.63% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Samsara Biocapital, Llc | 30 Sep 2025 | 5,612,896 |
| Eventide Asset Management, Llc | 30 Sep 2025 | 2,799,456 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 60.00 (UBS, 40.32%) | 购买 |
| 中 | 49.50 (15.76%) | |
| 低 | 42.00 (Wolfe Research, -1.78%) | 购买 |
| 平均值 | 49.67 (16.16%) | |
| 总计 | 6 购买 | |
| 平均价格@调整类型 | 39.22 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| UBS | 07 Jan 2026 | 60.00 (40.32%) | 购买 | 42.76 |
| Barclays | 17 Dec 2025 | 52.00 (21.61%) | 购买 | 44.01 |
| 17 Nov 2025 | 45.00 (5.24%) | 购买 | 36.47 | |
| JP Morgan | 18 Nov 2025 | 47.00 (9.92%) | 购买 | 39.81 |
| Wolfe Research | 18 Nov 2025 | 42.00 (-1.78%) | 购买 | 39.81 |
| Truist Securities | 20 Oct 2025 | 44.00 (2.90%) | 购买 | 27.92 |
| B of A Securities | 09 Oct 2025 | 53.00 (23.95%) | 购买 | 40.99 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合